Assenagon Asset Management S.A. Cara Therapeutics, Inc. Transaction History
Assenagon Asset Management S.A.
- $39.3 Billion
- Q2 2024
A detailed history of Assenagon Asset Management S.A. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 14,353 shares of CARA stock, worth $4,305. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,353
Previous 173,331
91.72%
Holding current value
$4,305
Previous $157,000
98.09%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CARA
# of Institutions
88Shares Held
16.5MCall Options Held
55KPut Options Held
500-
Vanguard Group Inc Valley Forge, PA2.25MShares$675,1000.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.94MShares$580,7150.01% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$510,6330.04% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$466,8750.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.07MShares$319,7250.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $16.1M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...